Search
Advanced search
Filter by category
Filter by committee
Search results
-
Pending approval from its board of directors, ASTM International announced yesterday the launch of a new committee focused on creating technical standards and guidance materials for cannabis and its products and processes. Yesterday, about 60 industry representatives, associations, and others convened at ASTM International’s global headquarters near Philadelphia and decided to create a volunteer…, Media Inquiries:, Nate Osburn, tel +1.610.832.9603; nosburn@astm.org, Committee Contact:, Robert Morgan, tel +1.610.832.9732; rmorgan@astm.org Release #10266
-
By request from industry, ASTM International will host an organizational meeting to potentially create a new technical committee that develops voluntary consensus standards for cannabis. The no-fee meeting is Tuesday, Feb. 28, at 9 a.m. EST at ASTM International’s global headquarters in, West Conshohocken, Pa., USA. Industry stakeholders and others interested in charting a path towards voluntary…, ASTM Cannabis Organizational Meeting:, Feb. 28, 2017, ASTM International, 100 Barr Harbor Drive, West Conshohocken, PA, 19428-2959 USA, Media Inquiries:, Nate Osburn, tel +1.610.832.9603; nosburn@astm.org, ASTM Staff Contact:, Christine DeJong, tel +1.610.832.9736; cdejong@astm.org Release #10251
-
Yesterday, Dr. Sudarsan Rachuri was given the 2016 ASTM International President’s Leadership Award. This recognizes individuals early in their ASTM International career who have significantly advanced the organization's mission through extraordinary accomplishment, example, and vision. Rachuri is serving as Editor-in-Chief of ASTM International’s new journal, Smart and Sustainable Manufacturing…, Media Inquiries:, Dan Bergels, tel +1.610.832.9602; dbergels@astm.org Release #10176
-
ASTM International and the Parenteral Drug Association recently signed a Memorandum of Understanding that launches a pilot to streamline efforts and conserve resources as both organizations develop technical guidance for the pharmaceutical industry. Katharine Morgan, executive vice president, ASTM, and Richard M. Johnson, president, PDA, signed the MOU. “The MOU between ASTM International and PDA…, ASTM Committee E55 on Manufacture of Pharmaceutical Products Next Meeting:, April 28-30, 2015, Lisbon, Portugal, Media Inquiries:, Nathan Osburn, tel +1.610.832.9603; nosburn@astm.org, ASTM Staff Contact:, Christine DeJong, tel +1.610.832.9736; cdejong@astm.org Release #9815 ###
-
Stakeholders in the field of industrial biotechnology, including representatives of the medical and pharmaceutical industries, the agricultural realm and other industries have joined together to form a new ASTM International technical committee. Following an organizational meeting on April 14, Committee E62 on Industrial Biotechnology was approved by the ASTM board of directors in June 2014. The…, ASTM Staff Contact:, Pat Picariello, Phone: 610-832-9720; ppicariello@astm.org , ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #9604
-
ASTM International Committee C08 on Refractories will celebrate its 100th anniversary on March 26 during the March 25-26 C08 meetings to be held in St. Louis, Mo., in conjunction with the St. Louis section of the American Ceramic Society. For more information on the March meetings and celebration, contact Kathleen McClung, manager, ASTM (phone: 610-832-9717; kmcclung@astm.org ). To register for…, ASTM Committee C08 Next Meeting:, March 25-26, 2014, St. Louis, Mo., ASTM Staff Contact:, Kathleen McClung, Phone: 610-832-9717; kmcclung@astm.org, ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #9578
-
ASTM International Committee E55 on Manufacture of Pharmaceutical Products is currently developing a proposed standard that will document a set of process steps that can reproducibly inactivate or remove any potential retrovirus in new biological products, particularly antibodies and antibody-like compounds. The proposed standard, ASTM WK39883 , Practice for Process of Inactivation of Enveloped…, ASTM Committee E55 Next Meeting:, April 9-11, 2013, Genzyme-A Sanofi Company, Haverhill, Suffolk, United Kingdom, Technical Contact:, John Schreffler, Ph.D., Morphotek Inc., Exton, Pa., Phone: 610-423-6557; jschreffler@morphotek.com, ASTM Staff Contact:, Christine DeJong, Phone: 610-832-9736; cdejong@astm.org, ASTM PR Contact:, Barbara Schindler, Phone: 610-832-9603; bschindl@astm.org Release #9327
-
Research and field experience have shown that fines free of clay and other harmful materials can be non-detrimental, and even beneficial, for concrete properties. A proposed new ASTM International standard will be used to distinguish between harmful and non-harmful fines in construction aggregate. ASTM WK36804 , Test Method for Rapid Determination of the Methylene Blue Value for Fine Aggregate…
-
A proposed new ASTM International standard will provide an important process step to be used in the manufacture of protein-based drugs, such as antibodies and fusion proteins, made to inactivate retroviruses. The proposed standard, ASTM WK36552 , Practice for Inactivation of Retrovirus by pH, is being developed by Subcommittee E55.04 on General Biopharmaceutical Standards , part of ASTM…
-
While the continuous quality verification concept is still quite new, it has the potential to become an important approach to assuring product quality in the pharmaceutical industry. With this in mind, ASTM International Committee E55 on Manufacture of Pharmaceutical Products has approved a new standard, E2537 , Guide for Application of Continuous Quality Verification to Pharmaceutical and…